Skip to main content

The Psychoneuroimmunological Influences of Recreational Marijuana

  • Conference paper
  • First Online:
New Trends and Advanced Methods in Interdisciplinary Mathematical Sciences

Abstract

Background: Marijuana is the most widely used illicit substance in the USA and self-reported use has remained steady over the past decade. Numerous publications examine the influence of marijuana use on various facets of human physiology including neurocognitive function, immune function, and illness symptom control, each discussing marijuana’s influence in a narrow or compartmentalized fashion. However, there is a scant literature discussing the empirical and clinical implications of the intersection of these constructs. The primary objective of this review is to review and synthesize this disparate literature and propose future research directions. Thus, this review examines the literature that relates the influence of marijuana to: (1) neurocognitive function; (2) immune function; (3) treatment uses; and (4) propose future directions.

Methods: Clinical and nonclinical empirical studies were collected and utilized to inform this review. The authors used PubMed search engine as the primary mechanism used to identify relevant articles.

Conclusion: Given the legalization efforts of recreational marijuana use, there is a need to discuss health and treatment effects of marijuana use from a more comprehensive, psychoneuroimmunological or biopsychosocial framework. We will discuss the need for an interdisciplinary research and future steps regarding the examination of marijuana use.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Substance Abuse and Mental Health Services Administration: Substance Abuse and Mental Health Services Administration, Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-48, HHS Publication No. (SMA) 14-4863. Rockville, MD (2014)

    Google Scholar 

  2. National Institute on Drug Abuse: Marijuana Retrieved from http://www.drugabuse.gov/publications/drugfacts/marijuana on August 6, 2015

  3. Vincent, B.J., McQuiston, D.J., Einhorn, L.H., Nagy, C.M., Brames, M.J.: Review of cannabinoids and their antiemetic effectiveness. Drugs. 25, 52–62 (1983)

    Article  Google Scholar 

  4. Li, H.L.: An archaeological and historical account of cannabis in China. Econ. Bot. 28(4), 437–448 (1973)

    Article  Google Scholar 

  5. Ben Amar, M.: Cannabinoids in medicine: a review of their therapeutic potential. J. Ethnopharmacol. 105(1), 1–25 (2006)

    Article  MathSciNet  Google Scholar 

  6. Pacula, R.L.: Marijuana use and policy: What we know and have yet to learn. NBER Reporter Online, (Winter 2004/05), 22–24 (2004)

    Google Scholar 

  7. Hall, W., Degenhardt, L.: Adverse health effects of non-medical cannabis use. Lancet. 374(9698), L1383–L1391 (2009)

    Article  Google Scholar 

  8. Hall, W.D., Lynskey, M.: Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs. Drug Alcohol Rev. 24(1), 39–48 (2005)

    Article  Google Scholar 

  9. Morral, A.R., McCaffrey, D.F., Paddock, S.M.: Reassessing the marijuana gateway effect. Addiction. 97(12), 1493–1504 (2002)

    Article  Google Scholar 

  10. Raphael, B., Wooding, S., Stevens, G., Connor, J.: Comorbidity: cannabis and complexity. J. Psychiatr. Pract. 11(3), 161–176 (2005)

    Article  Google Scholar 

  11. Tan, W.C., Lo, C., Jong, A., Xing, L., FitzGerald, M.J., Vollmer, W.M., Buist, S.A., Sin, D.D., Vancouver Burden of Obstructive Lung Disease (BOLD) Research Group: Marijuana and chronic obstructive lung disease: a population-based study. Can. Med. Assoc. J. 180(8), 814–820 (2009)

    Article  Google Scholar 

  12. Lundvquist, T.: Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacol. Biochem. Behav. 81, 319–330 (2005)

    Article  Google Scholar 

  13. Cousijn, J., Wiers, R.W., Ridderinkhof, K.R., Brink, W., Veltman, D.J., Porrino, L.J., Goudriaan, A.E.: Individual differences in decision making and reward processing predict changes in cannabis use: a prospective functional magnetic resonance imaging study. Addict. Biol. 18(6), 1013–1023 (2013)

    Article  Google Scholar 

  14. Klein, T.W., Friedman, H., Specter, S.: Marijuana, immunity and infection. J. Neuroimmunol. 83(1), 102–115 (1998)

    Article  Google Scholar 

  15. Jemmott, J.B., Locke, S.E.: Psychosocial factors, immunologic mediation, and human susceptibility to infectious diseases: how much do we know? Psychol. Bull. 95(1), 78 (1984)

    Article  Google Scholar 

  16. Maier, S.F., Watkins, L.R.: Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol. Rev. 105(1), 83 (1998)

    Article  Google Scholar 

  17. Suls, J., Rothman, A.: Evolution of the biopsychosocial model: prospects and challenges for health psychology. Health Psychol. 23(2), 119 (2004)

    Article  Google Scholar 

  18. ElSohly, M.A.: Marijuana and The Cannabinoids. Humana Press, Totowa, New Jersey (2007)

    Book  Google Scholar 

  19. Rom, S., Persidsky, Y.: Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation. J. NeuroImmune Pharmacol. 8(3), 608–620 (2013)

    Article  Google Scholar 

  20. Bhattacharyya, S., Fusar-Poli, P., Borgwardt, S., et al.: Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Arch. Gen. Psychiatry. 66(4), 442–451 (2009)

    Article  Google Scholar 

  21. Schoeler, T., Bhattacharyya, S.: The effect of cannabis use on memory function: an update. Subst. abuse Rehabil. 4, 11–27 (2013)

    Google Scholar 

  22. Crane, N.A., Schuster, R.M., Fusar-Poli, P., Gonzalez, R.: Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences. Neuropsychol. Rev. 23(2), 117–137 (2013)

    Article  Google Scholar 

  23. Fernández-Serrano, M.J., Pérez-García, M., Verdejo-García, A.: What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance? Neurosci. Biobehav. Rev. 35(3), 377–406 (2011)

    Article  Google Scholar 

  24. Wright, M.J., Vandewater, S.A., Taffe, M.A.: Cannabidiol attenuates deficits of visuospatial associative memory induced by Δ9tetrahydrocannabinol. Br. J. Pharmacol. 170(7), 1365–1373 (2013)

    Article  Google Scholar 

  25. Thames, A.D., Arbid, N., Sayegh, P.: Cannabis use and neurocognitive functioning in a non-clinical sample of users. Addict. Behav. 39(5), 994–999 (2014)

    Article  Google Scholar 

  26. Behan, B., Connolly, C.G., Datwani, S., Doucet, M., Ivanovic, J., Morioka, R., Stone, A., Watts, R., Smyth, B., Garavan, H.: Response inhibition and elevated parietal-cerrebellar correlations in chronic adolescent cannabis users. Neuropharmacology. 84, 131–137 (2014)

    Article  Google Scholar 

  27. Herkenham, M., Lynn, A.B., Little, M.D., Johnson, M.R., Melvin, L.S., de Costa, B.R., Rice, K.C.: Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. U. S. A. 87(5), 1932–1936 (1990)

    Article  Google Scholar 

  28. Vik, P.W., Cellucci, T., Jarchow, A., Hedt, J.: Cognitive impairment in substance abuse. Psychiatr. Clin. N. Am. 27(1), 97–109 (2004)

    Article  Google Scholar 

  29. Gonzalez, R.: Acute and non-acute effects of cannabis on brain functioning and neuropsychological performance. Neuropsychol. Rev. 17, 347–361 (2007)

    Article  Google Scholar 

  30. Ranganathan, M., D’Souza, D.C.: The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology. 188, 425–444 (2006)

    Article  Google Scholar 

  31. Mathew, R.J., Wilson, W.H.: Substance abuse and cerebral blood flow. Am. J. Psychiatry. 148, 292–305 (1991)

    Article  Google Scholar 

  32. Mathew, R.J., Wilson, W.H., Coleman, R.E., Turkington, T.G., DeGrado, T.R.: Marijuana intoxication and brain activation in marijuana smokers. Life Sci. 60(23), 2075–2089 (1997)

    Article  Google Scholar 

  33. Mathew, R.J., Wilson, W.H., Chiu, N.Y., Turkington, T.G., Coleman, R.E.: Regional cerebral blood flow and depersonalization after tetrahydrocannabinol adminstration. Acta Psychiatr. Scand. 100, 67–75 (1999a)

    Article  Google Scholar 

  34. Mathew, R.J., Wilson, W.H., Turkington, T.G., Coleman, R.E.: Cerebellar activity and disturbed time sense after THC. Brain Res. 797, 183–189 (1999b)

    Article  Google Scholar 

  35. Volkow, N.D., Gillespie, H., Mullani, N., Tancredi, L., Grant, C., Valentine, A., Holister, L.: Brain glucose metabolism in chronic marijuana users at baseline and during intoxication. Psychiatr. Res. Neuroimaging. 67, 29–38 (1996)

    Article  Google Scholar 

  36. Block, R.I., O’Leary, D.S., Hichwa, R.D., Augustinack, J.C., Boles Ponto, L.L., Ghoneim, M.M., Arndt, S., Hurtig, R.R., Watkins, G.L., Hall, J.A., Nathan, P.E.: Effects of frequent marijuana use on memory-related regional cerebral blood flow. Pharmacol. Biochem. Behav. 72, 237–250 (2002)

    Article  Google Scholar 

  37. Eldreth, D.A., Matochik, J.A., Cadet, J.L., Bolla, K.I.: Abnormal brain activity in prefrontal brain regions in abstinent marijuana users. NeuroImage. 23(3), 914–920 (2004)

    Article  Google Scholar 

  38. Jager, G., Block, R.I., Luijten, M., Ramsey, N.F.: Cannabis use and memory brain function in adolescent boys: a cross-sectional multicenter functional magnetic resonance imaging study. J. Am. Acad. Child Adolesc. Psychiatry. 49, 561–572 (2010)

    Google Scholar 

  39. Kanayama, G., Rogowska, J., Pope, H.G., Gruber, S.A., Yurgelynn-Todd, D.A.: Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study. Psychopharmacology. 176, 239–247 (2004)

    Article  Google Scholar 

  40. Tapert, S.F., Schweinsburg, A.D., Drummond, S.P., Paulus, M.P., Brown, S.A., Yang, T.T., Frank, L.R.: Functional MRI of inhibitory processing in abstinent adolescent marijuana users. Psychopharmacology. 194, 173–183 (2007)

    Article  Google Scholar 

  41. Bossong, M.G., Jager, G., Bhattacharyya, S., Allen, P.: Acute and non-acute effects of Cannabis on human memory function: a critical review of neuroimaging studies. Curr. Pharm. Des. 20(13), 2114–2125 (2014)

    Article  Google Scholar 

  42. Abdullaez, Y., Posner, M.I., Nunnally, R., Dishion, T.J.: Functional MRI evidence for inefficient attentional control in adolescent chronic cannabis abuse. Behav. Brain Res. 215, 45–47 (2010)

    Article  Google Scholar 

  43. Medina, K.L., Schweinsburg, A.D., Cohen-Zion, M., Nagel, B.J., Tapert, S.F.: Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry. Neurotoxicol. Teratol. 29, 141–152 (2007)

    Article  Google Scholar 

  44. Solowij, N., Michie, P.T., Fox, A.M.: Differential impairments of selective attention due to frequency and duration of cannabis use. Biol. Psychiatry. 15, 731–739 (1995)

    Article  Google Scholar 

  45. Solowij, N., Stephens, R., Roffman, R., Babor, T., Kadden, R., Miller, M., Christiansen, K., McRee, B., Vendetti, J., The Marijuana Project Research Group: Cognitive functioning of long-term heavy cannabis users seeking treatment. J. Am. Med. Assoc. 287, 1123–1131 (2002)

    Article  Google Scholar 

  46. Dougherty, D.M., Mathias, C.W., Dawes, M.A., Furr, R.M., Charles, N.E., Liguori, A., Shannon, E.E., Acheson, A.: Impulsivity, attention, memory, and decision-making among adolescent marijuana users. Psychopharmacology. 226(2), 307–319 (2013)

    Article  Google Scholar 

  47. Hanson, K.L., Winward, J.L., Schweinsburg, A.D., Medina, K.L., Brown, S.A., Tapert, S.F.: Longitudinal study of cognition among adolescent marijuana users over three weeks of abstinence. Addict. Behav. 35, 970–976 (2010)

    Article  Google Scholar 

  48. Harvey, M.A., Sellman, J.D., Porter, R.J., Frampton, C.M.: The relationship between non-acute adolescent cannabis use and cognition. Drug Alcohol Rev. 26, 309–319 (2007)

    Article  Google Scholar 

  49. Lisdahl, K.M., Price, J.S.: Increased marijuana use and gender predict poorer cognitive functioning in adolescents and emerging adults. J. Int. Neuropsychol. Soc. 18, 678–688 (2012)

    Article  Google Scholar 

  50. Mathias, C.W., Blumenthal, T.D., Dawes, M.A., Liguori, A., Richard, D.M., Bray, B., Tong, W., Dougherty, D.M.: Failure to sustain prepulse inhibition in adolescent marijuana users. Drug Alcohol Depend. 116, 110–116 (2011)

    Article  Google Scholar 

  51. McHale, S., Hunt, N.: Executive function deficits in short-term abstinent cannabis users. Hum. Psychopharmacol. Clin. Exp. 23, 409–415 (2008)

    Article  Google Scholar 

  52. Tapert, S.F., Granholm, E., Leedy, N.G., Brown, S.A.: Substance use and withdrawal: neuropsychological functioning over 8 years in youth. J. Int. Neuropsychol. Soc. 8, 873–883 (2002)

    Article  Google Scholar 

  53. Battisti, R.A., Roodenrys, S., Johnstone, S.J., Pesa, N., Hermens, D.F., Solowij, N.: Chronic cannabis user show altered neurophysiological functioning on Stroop task conflict resolution. Psychopharmacology. 212, 613–624 (2010)

    Article  Google Scholar 

  54. Day, A.M., Metrik, J., Spillane, N.S., Kahler, C.W.: Working memory and impulsivity predict marijuana-related problems among frequent users. Drug Alcohol Depend. 131(1), 171–174 (2013)

    Article  Google Scholar 

  55. Gonzalez, R., Schuster, R.M., Mermelstein, R.J., Vassileva, J., Martin, E.M., Diviak, K.R.: Performance of young adult cannabis users on neurocognitive measures of impulsive behavior and their relationship to symptoms of cannabis use disorders. J. Clin. Exp. Neuropsychol. 34, 962–976 (2012)

    Article  Google Scholar 

  56. Grant, J.E., Chamberlain, S.R., Schreiber, L., Odlaug, B.L.: Neuropsychological deficits associated with cannabis use in young adults. Drug Alcohol Depend. 121, 159–162 (2012)

    Article  Google Scholar 

  57. Pope, H.G., Yurgelun-Todd, D.: The residual cognitive effects of heavy marijuana use in college students. J. Am. Med. Assoc. 275, 521–527 (1996)

    Article  Google Scholar 

  58. Schuster, R.M., Crane, N.A., Mermelstein, R., Gonzalez, R.: The influence of inhibitory control and episodic memory on the risky sexual behavior of young adult cannabis users. J. Int. Neuropsychol. Soc. 18, 827–833 (2012)

    Article  Google Scholar 

  59. Solowij, N., Jones, K.A., Rozman, M.E., Davis, S.M., Ciarrochi, J., Heaven, P.C., Pesa, N., Lubman, D.I., Yücel, M.: Reflection impulsivity in adolescent cannabis users: a comparison with alcohol-using and non-substance-using adolescents. Psychopharmacology. 219, 575–586 (2012)

    Article  Google Scholar 

  60. Kalant, H.: Adverse effects of cannabis on health: an update of the literature since 1996. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 28(5), 849–863 (2004)

    Article  Google Scholar 

  61. Lyketsos, C.G., Garrett, E., Liang, K.Y., Anthony, J.C.: Cannabis use and cognitive decline in persons under 65 years of age. Am. J. Epidemiol. 149(9), 749–800 (1999)

    Article  Google Scholar 

  62. Pope Jr., H.G., Gruber, A.J., Hudson, J.I., Huestis, M.A., Yurgelun-Todd, D.: Neurpsychological performance in long-term cannabis users. Arch. Gen. Psychiatry. 58(10), 909–915 (2001)

    Article  Google Scholar 

  63. Bolla, K.I., Brown, K., Eldreth, D., Tate, K., Cadet, J.L.: Dose-related neurocognitive effects of marijuana use. Neurology. 59(9), 1337–1343 (2002)

    Article  Google Scholar 

  64. Wagner, D., Becker, B., Gouzoulis-Mayfrank, E., Daumann, J.: Interactions between specific parameters of cannabis use and verbal memory. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 34, 871–876 (2010)

    Article  Google Scholar 

  65. Becker, B., Wagner, D., Gouzoulis-Mayfrank, E.S., Daumann, J.: The impact of early-onset cannabis use on functional brain correlates of working memory. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 34, 837–845 (2010)

    Article  Google Scholar 

  66. Rieder, S.A., Chauhan, A., Singh, U., Nagarkatti, M., Nagarkatti, P.: Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression. Immunobiology. 215(8), 598–605 (2010)

    Article  Google Scholar 

  67. Suárez-Pinilla, P., López-Gil, J., Crespo-Facorro, B.: Immune system: a possible nexus between cannabinoids and psychosis. Brain Behav. Immun. 40, 269–282 (2014)

    Article  Google Scholar 

  68. Klein, T.W., Newton, C., Larsen, K., Lu, L., Perkins, I., Nong, L., Friedman, H.: The cannabinoid system and immune modulation. J. Leukoc. Biol. 74(4), 486–496 (2003)

    Article  Google Scholar 

  69. Crowe, M.S., Nass, S.R., Gabella, K.M., Kinsey, S.G.: The endocannabinoid system modulates stress, emotionality, and inflammation. Brain Behav. Immun. 42, 1–5 (2014)

    Article  Google Scholar 

  70. Herbert, T.B., Cohen, S.: Stress and immunity in humans: a meta-analytic review. Psychosom. Med. 55(4), 364–379 (1993)

    Article  Google Scholar 

  71. Pestonjamasp, V.K., Burstein, S.H.: Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system. Biochim. Biophys. Acta (BBA) Lipids Lipid Metab. 1394(2), 249–260 (1998)

    Article  Google Scholar 

  72. Croxford, J.L., Yamamura, T.: Cannabinids and the immune system: potential for the treatment of inflammatory diseases? J. Neuroimmunol. 165, 3–18 (2005)

    Article  Google Scholar 

  73. Munro, S., Thomas, K.L., Abu-Shaar, M.: Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365, 61–65 (1993)

    Article  Google Scholar 

  74. Miller, A.M., Stella, N.: CB2 receptor mediated migration of immune cells: it can go either way. Br. J. Pharmacol. 153(2), 299–308 (2008)

    Article  Google Scholar 

  75. Malfait, A.M., Gallily, R., Sumariwalla, P.F., Malik, A.S., Andreakos, E., Mechoulam, R., Feldmann, M.: The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. 97(17), 9561–9566 (2000)

    Article  Google Scholar 

  76. Klein, T.W., Newton, C., Friedman, H.: Cannabinoid receptors and immunity. Immunol. Today. 19(8), 373–381 (1998)

    Article  Google Scholar 

  77. Specter, S., Lancz, G., Hazelden, J.: Marijuana and immunity: tetrahydrocannabinol mediated inhibition of lymphocyte blastogenesis. Int. J. Immunopharmacol. 12(3), 261–267 (1990)

    Article  Google Scholar 

  78. Baldwin, G.C., Tashkin, D.P., Buckley, D.M., Park, A.N., Dubinett, S.M., Roth, M.D.: Marijuana and cocaine impair alveolar macrophage function and cytokine production. Am. J. Respir. Crit. Care Med. 156(5), 1606–1613 (1997)

    Article  Google Scholar 

  79. Keen II, L., Turner, A.D.: Differential effects of self-reported lifetime marijuana use on interleukin-1 alpha and tumor necrosis factor in African American adults. J. Behav. Med. 38, 527–534 (2015)

    Article  Google Scholar 

  80. Keen, L., Pereira, D., Latimer, W.: Self-reported lifetime marijuana use and interleukin-6 levels in middle-aged African Americans. Drug Alcohol Depend. 140, 156–160 (2014)

    Article  Google Scholar 

  81. Kozela, E., Juknat, A., Kaushansky, N., Rimmerman, N., Ben-Nun, A., Vogel, Z.: Cannabinoids decrease the 17th inflammatory autoimmune phenotype. J. NeuroImmune Pharmacol. 8(5), 1265–1276 (2013)

    Article  Google Scholar 

  82. Roth, M.D., Arora, A., Barsky, S.H., Kleerup, E.C., Simmons, M., Tashkin, D.P.: Airway inflammation in young marijuana and tobacco smokers. Am. J. Respir. Crit. Care Med. 157(3), 928–937 (1998)

    Article  Google Scholar 

  83. Pacifici, R., Zuccaro, P., Pichini, S., Roset, P.N., Poudevida, S., Farré, M., Segura, J., de la Torre, R.: Modulation of the immune system in cannabis users. JAMA. 289(15), 1929–1931 (2003)

    Article  Google Scholar 

  84. Pacifici, R., Zuccaro, P., Farré, M., Poudevida, S., Abanades, S., Pichini, S., Langohr, K., Segura, J., De La Torre, R.: Combined immunomodulating properties of 3, 4-methylenedioxymethamphetamine (MDMA) and cannabis in humans. Addiction. 102(6), 931–936 (2007)

    Article  Google Scholar 

  85. Roth, M.D., Whittaker, K., Salehi, K., Tashkin, D.P., Baldwin, G.C.: Mechanisms for impaired effector function in alveolar macrophages from marijuana and cocaine smokers. J. Neuroimmunol. 147(1), 82–86 (2004)

    Article  Google Scholar 

  86. Monnet-Tschudi, F., Hazekamp, A., Perret, N., Zurich, M.G., Mangin, P., Giroud, C., Honegger, P.: Delta-9-tetrahydrocannabinol accumulation, metabolism and cell-type-specific adverse effects in aggregating brain cell cultures. Toxicol. Appl. Pharmacol. 228(1), 8–16 (2008)

    Article  Google Scholar 

  87. Kozela, E., Pietr, M., Juknat, A., Rimmerman, N., Levy, R., Vogel, Z.: Cannabinoids Δ9-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-κB and interferon-β/STAT proinflammatory pathways in BV-2 microglial cells. J. Biol. Chem. 285(3), 1616–1626 (2010)

    Article  Google Scholar 

  88. Roth, M.D., Baldwin, G.C., Tashkin, D.P.: Effects of delta-9-tetrahydrocannabinol on human immune function and host defense. Chem. Phys. Lipids. 121(1), 229–239 (2002)

    Article  Google Scholar 

  89. Ongrandi, J., Spector, S., Horvath, A., Friedman, H.: Combined in vitro effect of marijuana and retrovirus on the activity of mouse natural killer cells. Pathol. Oncol. Res. 4(3), 191–199 (1998)

    Article  Google Scholar 

  90. Ngaotepprutaram, T., Kaplan, B.L., Kaminski, N.E.: Impaired NFAT and NFκB activation are involved in suppression of CD40 ligand expression by Δ 9-tetrahydrocannabinol in human CD4+ T cells. Toxicol. Appl. Pharmacol. 273(1), 209–218 (2013)

    Article  Google Scholar 

  91. Srivastava, M.D., Srivastava, B.I.S., Brouhard, B.: Δ 9 Tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells. Immunopharmacology. 40(3), 179–185 (1998)

    Article  Google Scholar 

  92. Yuan, M., Kiertscher, S.M., Cheng, Q., Zoumalan, R., Tashkin, D.P., Roth, M.D.: Δ 9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells. J. Neuroimmunol. 133(1), 124–131 (2002)

    Article  Google Scholar 

  93. Klein, T.W., Newton, C., Larsen, K., Chou, J., Perkins, I., Lu, L., Nong, L., Friedman, H.: Cannabinoid receptors and T helper cells. J. Neuroimmunol. 147(1), 91–94 (2004)

    Article  Google Scholar 

  94. Roth, M.D., Castaneda, J.T., Kiertscher, S.M.: Exposure to Δ9-tetrahydrocannabinol impairs the differentiation of human monocyte-derived dendritic cells and their capacity for T cell activation. J. NeuroImmune Pharmacol. 10(2), 333–343 (2015)

    Article  Google Scholar 

  95. Fischer-Stenger, K., Pettit, D.D., Cabral, G.A.: Delta 9-tetrahydrocannabinol inhibition of tumor necrosis factor-alpha: suppression of post-translational events. J. Pharmacol. Exp. Ther. 267(3), 1558–1565 (1993)

    Google Scholar 

  96. Kusher, D.I., Dawson, L.O., Taylor, A.C., Djeu, J.Y.: Effect of the psychoactive metabolite of marijuana delta9-tetrahydrocannabinol (thc), on the synthesis of tumor necrosis factor by human large granular lymphocites. Cell. Immunol. 154, 99–108 (1994)

    Article  Google Scholar 

  97. Snella, E., Pross, S., Friedman, H.: Relationship of aging and cytokines to the immunomodulation by delta-9-tetrahydrocannabinol on murine lymphoid cells. Int. J. Immunopharmacol. 17(12), 1045–1054 (1995)

    Article  Google Scholar 

  98. Wang, M., Richards, A.L., Friedman, H., Djeu, J.Y.: Selective inhibition of natural killer but not natural cytotoxic activity in a cloned cell line by delta-9-tetrahydrocannabinol. J. Leukoc. Biol. 50(2), 192–197 (1991)

    Google Scholar 

  99. Newton, C.A., Klein, T.W., Friedman, H.: Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection. Infect. Immun. 62(9), 4015–4020 (1994)

    Google Scholar 

  100. Massi, P., Sacerdote, P., Ponti, W., Fuzio, D., Manfredi, B., Viganó, D., Rubino, T., Bardotti, M., Parolaro, D.: Immune function alterations in mice tolerant to Δ 9-tetrahydrocannabinol: functional and biochemical parameters. J. Neuroimmunol. 92(1), 60–66 (1998)

    Article  Google Scholar 

  101. Klein, T.W., Newton, C.A., Nakachi, N., Friedman, H.: Δ9-tetrahydrocannabinol treatment suppresses immunity and early IFN-γ, IL-12, and IL-12 receptor β2 responses to Legionella pneumophila infection. J. Immunol. 164(12), 6461–6466 (2000)

    Article  Google Scholar 

  102. Newton, C.A., Lu, T., Nazian, S.J., Perkins, I., Friedman, H., Klein, T.W.: The THC-induced suppression of Th1 polarization in response to Legionella pneumophila infection is not mediated by increases in corticosterone and PGE2. J. Leukoc. Biol. 76(4), 854–861 (2004)

    Article  Google Scholar 

  103. Gaffal, E., Cron, M., Glodde, N., Tüting, T.: Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors. Allergy. 68(8), 994–1000 (2013)

    Article  Google Scholar 

  104. Zhu, L.X., Sharma, S., Stolina, M., Gardner, B., Roth, M.D., Tashkin, D.P., Dubinett, S.M.: Δ-9-Tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J. Immunol. 165(1), 373–380 (2000)

    Article  Google Scholar 

  105. Chang, Y.H., Lee, S.T., Lin, W.W.: Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids. J. Cell. Biochem. 81(4), 715–723 (2001)

    Article  Google Scholar 

  106. Lu, T., Newton, C., Perkins, I., Friedman, H., Klein, T.W.: Cannabinoid treatment suppresses the T-helper cell-polarizing function of mouse dendritic cells stimulated with Legionella pneumophila infection. J. Pharmacol. Exp. Ther. 319(1), 269–276 (2006)

    Article  Google Scholar 

  107. Verhoeckx, K.C., Korthout, H.A., van Meeteren-Kreikamp, A.P., Ehlert, K.A., Wang, M., van der Greef, J., Rodenburg, R.J., Witkamp, R.F.: Unheated Cannabis sativa extracts and its major compound THC-acid have potential immuno-modulating properties not mediated by CB 1 and CB 2 receptor coupled pathways. Int. Immunopharmacol. 6(4), 656–665 (2006)

    Article  Google Scholar 

  108. McKallip, R.J., Nagarkatti, M., Nagarkatti, P.S.: Δ-9-Tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response. J. Immunol. 174(6), 3281–3289 (2005)

    Article  Google Scholar 

  109. Ramarathinam, L., Pross, S., Plescia, O., Newton, C., Widen, R., Friedman, H.: Differential immunologic modulatory effects of tetrahydrocannabinol as a function of age. Mech. Ageing Dev. 96(1), 117–126 (1997)

    Article  Google Scholar 

  110. Alshaarawy, O., Anthony, J.C.: Cannabis smoking and serum C-reactive protein: a quantile regressions approach based on NHANES 2005–2010. Drug Alcohol Depend. 147, 203–207 (2015)

    Article  Google Scholar 

  111. Muniyappa, R., Sable, S., Ouwerkerk, R., Mari, A., Gharib, A.M., Walter, M., Courville, A., Hall, G., Chen, K.Y., Volkow, N.D., Kunos, G.: Metabolic effects of chronic cannabis smoking. Diabetes Care. 36(8), 2415–2422 (2013)

    Article  Google Scholar 

  112. Costello, E.J., Copeland, W.E., Shanahan, L., Worthman, M., Angold, A.: C-reactive protein and substance use disorders in adolescence and early adulthood: a prospective analysis. Drug Alcohol Depend. 133(2), 712–717 (2013)

    Article  Google Scholar 

  113. Rajavashisth, T.B., Shaheen, M., Norris, K.C., Pan, D., Sinha, S.K., Ortega, J., Friedman, T.C.: Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III. BMJ Open. 2(1), e000494 (2012)

    Article  Google Scholar 

  114. Ugen, K.E., Nyland, S.B.: Injecting drugs of abuse and immunity: implications for HIV vaccine testing and efficacy. Semin. Immunopathol. 28(3), 281–287 (2006)

    Article  Google Scholar 

  115. Cescon, D.W., Page, A.V., Richardson, S., Moore, M.J., Boerner, S., Gold, W.L.: Invasive pulmonary aspergillosis associated with marijuana use in a man with colorectal cancer. J. Clin. Oncol. 26(13), 2214–2215 (2008)

    Article  Google Scholar 

  116. Ruchlemer, R., Amit-Kohn, M., Raveh, D., Hanuš, L.: Inhaled medicinal cannabis and the immunocompromised patient. Support. Care Cancer. 23(3), 819–822 (2015)

    Article  Google Scholar 

  117. Szyper-Kravitz, M., Lang, R., Manor, Y., Lahav, M.: Early invasive pulmonary aspergillosis in a leukemia patient linked to aspergillus contaminated marijuana smoking. Leuk. Lymphoma. 42(6), 1433–1437 (2001)

    Article  Google Scholar 

  118. Cabral, G.A., Pettit, D.A.D.: Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease. J. Neuroimmunol. 83(1), 116–123 (1998)

    Article  Google Scholar 

  119. Huemer, H.P., Lassnig, C., Bernhard, D., Sturm, S., Nowotny, N., Kitchen, M., Pavlic, M.: Cannabinoids lead to enhanced virulence of the smallpox vaccine (vaccinia) virus. Immunobiology. 216(6), 670–677 (2011)

    Article  Google Scholar 

  120. Lee, M.A.: The Discovery of the Endocannabinoid system. Retrieved from http://www.beyondthc.com/wp-content/uploads/2012/07/eCBSystemLee.pdf (2010)

  121. Fischer, B., Murphy, Y., Kurdyak, P., Goldner, E., Rehm, J.: Medical Marijuana Programs-why might they matter for public health and why should we better understand their impacts? Prev. Med. Rep. 2, 53–56 (2015)

    Article  Google Scholar 

  122. Philipsen, N., Butler, R.D., Simon-Waterman, C., Artis, J.: Medical marijuana: a primer on ethics, evidence, and politics. J. Nurse Pract. 10(9), 633–640 (2014)

    Article  Google Scholar 

  123. Klein, T.W.: Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat. Rev. Immunol. 5(5), 400–411 (2005)

    Article  Google Scholar 

  124. Klein, T.W., Cabral, G.A.: Cannabinoid-induced immune suppression and modulation of antigen-presenting cells. J. NeuroImmune Pharmacol. 1(1), 50–64 (2006)

    Article  Google Scholar 

  125. Sylvestre, D.L., Clements, B.J., Malibu, Y.: Cannabis use improves retention and virological outcomes in patients treated for hepatitis C. Eur. J. Gastroenterol. Hepatol. 18(10), 1057–1063 (2006)

    Article  Google Scholar 

  126. Lorente, M., Torres, S., Salazar, M., Carracedo, A., Hernández-Tiedra, S., Rodríguez-Fornés, F., Garcia-Taboada, E., Meléndez, B., Mollejo, M., Campos-Martin, Y., Lakatosh, S.A.: Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action. Cell Death Differ. 18(6), 959–973 (2011)

    Article  Google Scholar 

  127. Naftali, T., Lev, L.B., Yablecovitch, D., Half, E., Konikoff, F.M.: Treatment of Crohn’s disease with cannabis: an observational study. Isr. Med. Assoc. J. 13(8), 455–458 (2011)

    Google Scholar 

  128. Waldman, M., Hochhauser, E., Fishbein, M., Aravot, D., Shainberg, A., Sarne, Y.: An ultra-low dose of tetrahydrocannabinol provides cardioprotection. Biochem. Pharmacol. 85(11), 1626–1633 (2013)

    Article  Google Scholar 

  129. Maier, S.F., Watkins, L.R., Fleshner, M.: Psychoneuroimmunology: the interface between behavior, brain, and immunity. Am. Psychol. 49(12), 1004 (1994)

    Article  Google Scholar 

  130. Schreiner, A.M., Dunn, M.E.: Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: a meta-analysis. Exp. Clin. Psychopharmacol. 20, 420–429 (2012)

    Article  Google Scholar 

Download references

Role of Funding Source

This project was supported by grant #P20 MD000512 from National Center on Minority Health and Health Disparities.

Conflict of Interest

No conflict declared.

Contributors

Drs. Keen II, Turner, Pereira, Callender, and Campbell contributed to the literature search and writing/editing of this article and have approved the final article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Larry Keen II .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this paper

Cite this paper

Keen, L., Turner, A.D., Pereira, D., Callender, C., Campbell, A. (2017). The Psychoneuroimmunological Influences of Recreational Marijuana. In: Toni, B. (eds) New Trends and Advanced Methods in Interdisciplinary Mathematical Sciences. STEAM-H: Science, Technology, Engineering, Agriculture, Mathematics & Health. Springer, Cham. https://doi.org/10.1007/978-3-319-55612-3_5

Download citation

Publish with us

Policies and ethics